University of PittsburghUniversity of Pittsburgh
Technologies
TechnologiesStartupsExpress LicensesCollectionsChat with AI
Sign in
University of Pittsburgh

Novel Therapy to Prevent Liver Disease

OverviewRequest InfoMore Like ThisExpress Licenses

Technology Type

Diagnostic/Assay

Technology Subtype

In vitro Diagnostic

Therapeutic Areas

Hepatology

Therapeutic Indications

Non-alcoholic steatohepatitis (NASH)Cirrhosis

Tags

Genetics

Lead Inventor

Alejandro Soto Gutierrez

Department

Med-Pathology

All Innovators

Abhinav AchrejaOlamide AnimasahunRodrigo Machado FlorentinoNils HaepKazutoyo MoritaDeepak Nagrath PhDAlejandro Soto GutierrezKazuki TakeishiTomoharu Yoshizumi MD, PhD, FACS

Date Submitted

Jun 10, 2021

Reference Number

05722

University of Pittsburgh, Kyushu University, and University of Michigan researchers have identified a key pathway involved in the development of cirrhosis with targets to prevent liver disease, thereby reducing the need for liver transplantation.

Description

Previous work has demonstrated a link between a variant on the PNPLA3 gene, rs738409:G, a gene found in 30–50% of the global population, hepatic steatosis, and accumulation of triglycerides in hepatocytes. Novel work has now discovered that lipid peroxidation of polyunsaturated fatty acids (PUFAs) and ferroptosis, a form of iron-dependent cell death are key drivers in the development of liver cirrhosis in carriers of this variant. Targeting the ferroptosis pathway could be a novel approach to preventing liver cirrhosis in carriers of the rs738409:G variant on PNPLA3.

Applications

1. Hepatic steatosis
2. Nonalcoholic steatohepatitis (NASH)
3. Alcoholic and non-alcoholic cirrhosis
4. Hepatocellular carcinoma

Advantages

This novel approach exploits the recently discovered role of ferroptosis in the development of liver cirrhosis in people with the rs738409:G variant on PNPLA3. Through identification of compounds capable of inhibiting ferroptosis, this approach could provide a non-invasive treatment strategy for cirrhosis, including a reduced need for liver transplantation.

Invention Readiness

The role of ferroptosis in the development of cirrhosis in people with the rs738409:G variant on the gene PNPLA3 has been identified. Inhibition of ferroptosis has been shown to improve survival in vitro.

IP Status

https://patents.google.com/patent/WO2023092134A1

Related Publication(s)

Kocas-Kilicarslan, Z. N., Cetin, Z., Faccioli, L. A. P., Motomura, T., Amirneni, S., Diaz-Aragon, R., Florentino, R. M., Sun, Y., Pla-Palacin, I., Xia, M., Miedel, M. T., Kurihara, T., Hu, Z., Ostrowska, A., Wang, Z., Constantine, R., Li, A., Taylor, D. L., Behari, J., … Tafaleng, E. N. (2024). Polymorphisms Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease Influence the Progression of End-Stage Liver Disease. Gastro Hep Advances, 3(1), 67–77. https://doi.org/10.1016/j.gastha.2023.09.011

Faccioli, L. A. P., Cetin, Z., Kocas-Kilicarslan, Z. N., Ortiz, K., Sun, Y., Hu, Z., Kurihara, T., Tafaleng, E. N., Florentino, R. M., Wang, Z., Xia, M., Miedel, M. T., Taylor, D. L., Behari, J., Ostrowska, A., Constantine, R., Li, A., & Soto-Gutierrez, A. (2023). Evaluation of Human Hepatocyte Drug Metabolism Carrying High-Risk or Protection-Associated Liver Disease Genetic Variants. International Journal of Molecular Sciences, 24(17), 13406. https://doi.org/10.3390/ijms241713406

Discover More with AI